Kashiv BioSciences

Kashiv Bio Sciences

Pharmaceuticals, Bridgewater, New Jersey, 08807, United States, 201-500 Employees

kashivpharma.com

  • facebook
  • LinkedIn

phone no Phone Number: 73********

Who is KASHIV BIOSCIENCES

Kashiv BioSciences, LLC is a fully integrated biosciences company headquartered in Bridgewater, New Jersey with locations in Piscataway, NJ, Chicago IL, and Ahmedabad, India. Kashiv BioSc...

Read More

map
  • Bridgewater, New Jersey, 08807, United States Headquarters: Bridgewater, New Jersey, 08807, United States
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $25 Million to $50 Million

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2836 | NAICS Code: 621111 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from KASHIV BIOSCIENCES

Kashiv BioSciences Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Kashiv BioSciences

Answer: Kashiv BioSciences's headquarters are located at Bridgewater, New Jersey, 08807, United States

Answer: Kashiv BioSciences's phone number is 73********

Answer: Kashiv BioSciences's official website is https://kashivpharma.com

Answer: Kashiv BioSciences's revenue is $25 Million to $50 Million

Answer: Kashiv BioSciences's SIC: 2836

Answer: Kashiv BioSciences's NAICS: 621111

Answer: Kashiv BioSciences has 201-500 employees

Answer: Kashiv BioSciences is in Pharmaceuticals

Answer: Kashiv BioSciences contact info: Phone number: 73******** Website: https://kashivpharma.com

Answer: Kashiv BioSciences, LLC is a fully integrated biosciences company headquartered in Bridgewater, New Jersey with locations in Piscataway, NJ, Chicago IL, and Ahmedabad, India. Kashiv BioSciences broad business offering includes drug delivery platforms incorporating delayed release technology and gastric retention systems that improve the efficacy and safety of known drugs, a 505(b)(2) pipeline of development products targeting unmet clinical needs, biosimilars and prodrugs. Additionally, as part of a development collaboration Kashiv BioSciences has approved generic products and products in advanced stages of development, including several complex generic products. Kashiv BioSciences medications will improve the lives of patients suffering from cancer as well as neuromuscular, movement and endocrine disorders, among other debilitating conditions, both in the U.S. and globally. The combined breadth of expertise in small and large molecules, peptides, proteins and monoclonal antibodies enables Kashiv BioSciences to develop products with meaningful clinical differentiation and a compelling value proposition for patients, physicians and payers.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access